10.1002/jhet.5570220112
The research aimed to develop new organ-specific radiopharmaceuticals by synthesizing compounds containing the 4-phenylpiperazine moiety, which is known for its selective mechanisms of action and ability to undergo electrophilic substitution reactions. The study successfully synthesized 4(4-iodophenyl)piperazine (2) with a 70% yield and characterized it. This compound was then converted to its 1-carboxamidino derivative (4) with a 61% yield, using S-methylthiouronium sulfate. The researchers chose a milder reaction condition to avoid separation problems and complex mixtures that resulted from higher temperatures. The study concluded that the synthesized compounds could be potential candidates for myocardial imaging radiopharmaceuticals, as the 1-carboxamidino derivative showed identical properties to the radioiodinated material previously evaluated for this purpose. Key chemicals used in the research included 4-phenylpiperazine, iodine monochloride, S-methylthiouronium sulfate, and various solvents such as acetic acid-water mixture and dimethyl sulfoxide.
10.1248/cpb.50.453
The study focuses on the synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives, which were identified as potential antiproliferative agents. These compounds were designed to increase antitumor activity while reducing side effects associated with muscle relaxation and decreased body temperature. The research involved the structural modification of a specific chemical scaffold, particularly the phenylpiperazine moiety, by introducing substituents on the phenyl ring and replacing the phenylpiperazinyl group with piperidinyl groups. The chemicals used in the study included various aniline derivatives, piperazines, and pyrazole derivatives, as well as reagents for synthetic procedures such as bis(2-chloroethyl)amine hydrochloride, p-toluenesulfonic acid, sodium borohydride, and osmium tetraoxide. These chemicals served the purpose of constructing and modifying the target pyrimidinyl pyrazole derivatives to evaluate their in vitro cytotoxic activity against human lung cancer cell lines and their in vivo antitumor activity in murine tumor models. The study aimed to optimize the structure-activity relationship of these derivatives to enhance their efficacy as antitumor agents without causing significant side effects.